small-molecule pharmaceutical sales annually
(small & large molecule) annual pharmaceutical sales in the US alone
of these small-molecule drugs are constrained by poor delivery of APIs, onerous treatment regimens, slow action times/unwanted side effects
Explore our vision, strategy, and capabilities.
Want to know more?
Exploring new technologies in pharmaceuticals and their applications to address unmet medical needs remains of paramount interest to us.
We are committed to making the promise of nanomedicines a reality by delivering clinically superior and cost-effective nanotherapeutics that beat the current gold standards in medicine and significantly improve the quality of global healthcare.